With a staggering 537 million adults already living with diabetes worldwide—a number set to soar to 783 million by 2045—this silent epidemic is exacting a devastating human and economic toll that demands our immediate attention.
Key Takeaways
- In 2021, approximately 537 million adults (aged 20-79 years) were living with diabetes worldwide, representing 10.5% of this age group
- By 2045, the global diabetes prevalence among adults aged 20-79 years is projected to reach 783 million, an increase of 46%
- In 2021, 46% of adults with diabetes worldwide (240 million people) were undiagnosed
- In 2021, diabetes caused 6.7 million deaths worldwide, equivalent to one death every 5 seconds
- Diabetes accounted for 12.2% of all deaths globally in adults aged 20-79 years in 2021
- In 2021, 3.4 million deaths from diabetes were in low- and middle-income countries
- The global economic burden of diabetes was estimated at USD 966 billion in 2021, representing 9.4% of total health expenditure
- Direct healthcare costs for diabetes worldwide reached USD 460 billion in 2021 for adults aged 20-79
- Indirect costs (lost productivity) from diabetes amounted to USD 506 billion globally in 2021
- Overweight and obesity contributed to 44% of the diabetes disease burden globally in 2021
- Physical inactivity accounts for 6.8% of diabetes cases worldwide
- 90% of type 2 diabetes cases are linked to modifiable lifestyle factors globally
- Only 11% of people with diabetes worldwide had access to insulin in low-income countries in 2021
- Globally, 49% of type 2 diabetes patients achieved HbA1c <7% target in 2021 surveys
- Blood glucose monitoring strips cost prohibitive for 80% in low-income settings
Global diabetes cases are rising rapidly and will impact nearly 800 million adults by 2045.
Economic Impact
1The global economic burden of diabetes was estimated at USD 966 billion in 2021, representing 9.4% of total health expenditure
Verified2Direct healthcare costs for diabetes worldwide reached USD 460 billion in 2021 for adults aged 20-79
Verified3Indirect costs (lost productivity) from diabetes amounted to USD 506 billion globally in 2021
Verified4By 2045, total diabetes-related health expenditure is projected to reach USD 1 trillion worldwide
Directional5In high-income countries, per capita diabetes health spending was USD 1,917 in 2021
Single source6Low-income countries spent only USD 682 per person with diabetes on health in 2021
Verified7USA diabetes costs totaled USD 412.9 billion in 2022, up from previous years
Verified8Globally, 40% of diabetes expenditure in 2021 was on hospitalizations
Verified9China’s diabetes economic burden was USD 102 billion in 2021
Directional10In the EU, diabetes cost €129 billion annually around 2021
Single source11Lost productivity from diabetes premature mortality was USD 251 billion globally in 2021
Verified12India faced USD 64 billion in diabetes costs in 2021, projected to USD 106 billion by 2045
Verified13In MENA region, diabetes expenditure was USD 18.3 billion in 2021
Verified14Brazil's direct diabetes costs reached USD 3.5 billion in 2021
Directional15Globally, insulin costs represent 11% of total diabetes expenditure in 2021
Single source16Workplace absenteeism due to diabetes costs USD 27 billion annually worldwide circa 2021
Verified17In 2021, Germany spent €28.3 billion on diabetes care
Verified18Sub-Saharan Africa diabetes costs were USD 9 billion in 2021
VerifiedEconomic Impact Interpretation
The staggering global diabetes bill—nearing a trillion dollars and set to keep climbing—reveals a world where we're paying exorbitantly in both cash and human potential to treat a crisis we should be far smarter about preventing.
Mortality/Morbidity
1In 2021, diabetes caused 6.7 million deaths worldwide, equivalent to one death every 5 seconds
Verified2Diabetes accounted for 12.2% of all deaths globally in adults aged 20-79 years in 2021
Verified3In 2021, 3.4 million deaths from diabetes were in low- and middle-income countries
Verified4Cardiovascular disease caused 24% of diabetes-related deaths in 2021 globally
Directional5Globally, diabetes reduced life expectancy by 3 years on average in 2021 for those aged 20-79
Single source6In 2021, kidney disease accounted for 11% of deaths among people with diabetes worldwide
Verified7People with diabetes have a 2-3 times higher risk of heart attack or stroke compared to non-diabetics
Verified8In 2021, 47% of diabetes-related deaths occurred before age 70 worldwide
Verified9Diabetes complications led to 1.5 million disability-adjusted life years (DALYs) lost globally per million population in 2021
Directional10In low-income countries, diabetes mortality rate was 92 per 100,000 in 2021
Single source11Globally, 541,000 deaths from diabetes occurred in women aged 20-79 in 2021
Verified12Chronic kidney disease prevalence among diabetics was 30-40% worldwide in 2021
Verified13Diabetes retinopathy affects up to 80% of people with long-standing type 2 diabetes globally
Verified14In 2021, foot ulcers affected 6.3% of diabetics worldwide, leading to 1 million leg amputations annually
Directional15Neuropathy prevalence in diabetes patients reached 50% globally in recent studies
Single source16Hospitalization rates for diabetes complications were 2.5 times higher in diabetics vs non-diabetics worldwide
Verified17In 2021, diabetes contributed to 13% of total cardiovascular deaths globally
Verified18Global years lived with disability (YLDs) due to diabetes increased by 28% from 1990 to 2021
Verified19In Africa, diabetes mortality rate was projected to double by 2045 from 2021 levels
DirectionalMortality/Morbidity Interpretation
The grim clockwork of diabetes ticks with a ruthless, global rhythm, stealing a life every five seconds and chipping away at years, hearts, kidneys, and limbs from the wealthy nations to the most vulnerable, where its shadow grows longest and darkest.
Prevalence/Incidence
1In 2021, approximately 537 million adults (aged 20-79 years) were living with diabetes worldwide, representing 10.5% of this age group
Verified2By 2045, the global diabetes prevalence among adults aged 20-79 years is projected to reach 783 million, an increase of 46%
Verified3In 2021, 46% of adults with diabetes worldwide (240 million people) were undiagnosed
Verified4The highest diabetes prevalence rates in 2021 were in the MENA region at 12.2% for adults aged 20-79 years
Directional5Globally, diabetes prevalence among adults aged 20-79 years was higher in urban (10.8%) than rural (7.2%) areas in 2021
Single source6In 2021, there were 24 million children and adolescents (0-19 years) living with diabetes worldwide
Verified7The Western Pacific region had the largest number of adults with diabetes in 2021 at 206 million
Verified8Diabetes incidence among adults aged 20-79 years is expected to increase by 17% globally from 2021 to 2045
Verified9In low-income countries, diabetes prevalence rose from 3.6% in 1990 to 5.5% in 2021 among adults
Directional10South-East Asia had 90 million adults with diabetes in 2021, projected to 151 million by 2045
Single source11Globally, 1 in 9 adults aged 20-79 years (10.5%) had diabetes in 2021
Verified12In 2021, Africa had the lowest diabetes prevalence at 4.5% but highest projected increase of 129% by 2045
Verified13Women worldwide had a diabetes prevalence of 10.1% compared to 10.9% in men aged 20-79 in 2021
Verified14The number of adults with diabetes in high-income countries was 123 million in 2021
Directional15In 2021, 44 million adults aged 20-79 years in the United States had diabetes
Single source16Global diabetes prevalence in adults aged 65+ was 17.5% in 2021
Verified17Middle East and North Africa region saw diabetes cases rise from 20 million in 2000 to 73 million in 2021
Verified18In 2021, 529 million adults lived with diabetes globally, with China having 140 million cases
Verified19Europe had 61 million adults with diabetes in 2021, prevalence 6.9%
Directional20Global age-standardized diabetes prevalence increased from 4.7% in 1980 to 6.1% in 2021
Single sourcePrevalence/Incidence Interpretation
We are losing the global race between our health and our habits, with nearly half the competitors unknowingly running blindfolded toward a finish line where one in ten of us is already diabetic and the crowd of 783 million waiting in 2045 looks worryingly like a grim victory parade.
Risk Factors/Causes
1Overweight and obesity contributed to 44% of the diabetes disease burden globally in 2021
Verified2Physical inactivity accounts for 6.8% of diabetes cases worldwide
Verified390% of type 2 diabetes cases are linked to modifiable lifestyle factors globally
Verified4Smoking increases type 2 diabetes risk by 30-40% according to global meta-analyses
Directional5Gestational diabetes affects 14% of pregnancies worldwide, raising future type 2 risk
Single source6Family history doubles the risk of type 2 diabetes globally
Verified7High blood pressure is present in 50% of people with type 2 diabetes worldwide
Verified8Polycystic ovary syndrome (PCOS) increases diabetes risk 3-7 fold in women globally
Verified9Age over 45 years raises diabetes risk significantly, with prevalence doubling every decade
Directional10South Asians have 2-4 times higher diabetes risk at lower BMI levels than Europeans
Single source11Excessive alcohol consumption increases diabetes risk by 43% per global studies
Verified12Poor sleep (less than 6 hours/night) raises diabetes risk by 28% worldwide
Verified13Air pollution exposure linked to 10-20% increased diabetes incidence in urban areas globally
Verified14Low birth weight infants have 2-fold higher risk of type 2 diabetes in adulthood
Directional15Shift work disrupts circadian rhythms, increasing diabetes risk by 9% per meta-analysis
Single source16Depression is associated with 60% higher diabetes risk globally
Verified17Chronic stress elevates cortisol, contributing to 20-30% higher diabetes incidence
Verified18High fructose corn syrup consumption correlates with rising diabetes rates in 40 countries
Verified19Vitamin D deficiency linked to 43% increased diabetes risk in global cohorts
Directional20Sedentary behavior (over 10 hours/day) raises risk by 112% according to WHO data
Single sourceRisk Factors/Causes Interpretation
If humanity held a referendum on type 2 diabetes, the overwhelming vote would be for a platform of modern living—where our chairs, screens, stress, and snacks are the primary campaigners, and genetics is merely the unfortunate running mate.
Treatment/Management
1Only 11% of people with diabetes worldwide had access to insulin in low-income countries in 2021
Verified2Globally, 49% of type 2 diabetes patients achieved HbA1c <7% target in 2021 surveys
Verified3Blood glucose monitoring strips cost prohibitive for 80% in low-income settings
Verified4Metformin is used by 80% of type 2 diabetes patients as first-line therapy worldwide
Directional5Continuous glucose monitoring (CGM) adoption was under 1% globally outside high-income countries in 2021
Single source6Statins prescribed to only 40% of diabetics despite CVD risk guidelines worldwide
Verified7Diabetes self-management education reaches less than 50% of patients globally
Verified8GLP-1 receptor agonists used by 5% of type 2 patients in Europe, lower elsewhere in 2021
Verified9Foot care screening performed in only 20-30% of diabetes clinics worldwide annually
Directional10Retinopathy screening coverage was 60% in high-income vs 10% in low-income countries in 2021
Single source11Bariatric surgery recommended for BMI>35 with diabetes, but access <1% globally
Verified12ACE inhibitors for nephropathy in 50% of eligible diabetics worldwide circa 2021
Verified13Lifestyle interventions reduce diabetes incidence by 58% in high-risk groups per DPP study global adaptations
Verified14SGLT2 inhibitors adopted by 10% of type 2 patients in 2021, mainly high-income
Directional15Aspirin prophylaxis in 30% of high-risk diabetics globally despite guidelines
Single sourceTreatment/Management Interpretation
The global diabetes care landscape is a tale of two worlds: a frustrating farce where we possess nearly all the effective tools yet choose, through neglect and inequity, to let most patients fight a losing battle with a half-empty toolbox.
Sources & References
- Reference 1DIABETESATLASdiabetesatlas.orgVisit source
- Reference 2IDFidf.orgVisit source
- Reference 3WHOwho.intVisit source
- Reference 4CDCcdc.govVisit source
- Reference 5NCBIncbi.nlm.nih.govVisit source
- Reference 6THELANCETthelancet.comVisit source
- Reference 7KIDNEYkidney.orgVisit source
- Reference 8NEInei.nih.govVisit source
- Reference 9OECDoecd.orgVisit source
- Reference 10AHAJOURNALSahajournals.orgVisit source
- Reference 11DIABETESdiabetes.orgVisit source
- Reference 12ECec.europa.euVisit source
- Reference 13NIDDKniddk.nih.govVisit source
- Reference 14DIABETESJOURNALSdiabetesjournals.orgVisit source
- Reference 15NEJMnejm.orgVisit source